BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8036016)

  • 1. Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells.
    Thakur S; Lin HC; Tseng WT; Kumar S; Bravo R; Foss F; Gélinas C; Rabson AB
    Oncogene; 1994 Aug; 9(8):2335-44. PubMed ID: 8036016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
    Kim KE; Gu C; Thakur S; Vieira E; Lin JC; Rabson AB
    Oncogene; 2000 Mar; 19(10):1334-45. PubMed ID: 10713675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
    Fracchiolla NS; Lombardi L; Salina M; Migliazza A; Baldini L; Berti E; Cro L; Polli E; Maiolo AT; Neri A
    Oncogene; 1993 Oct; 8(10):2839-45. PubMed ID: 8378093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.
    Zhang J; Chang CC; Lombardi L; Dalla-Favera R
    Oncogene; 1994 Jul; 9(7):1931-7. PubMed ID: 8208540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
    Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
    Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
    Naumann M; Nieters A; Hatada EN; Scheidereit C
    Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.
    Ciana P; Neri A; Cappellini C; Cavallo F; Pomati M; Chang CC; Maiolo AT; Lombardi L
    Oncogene; 1997 Apr; 14(15):1805-10. PubMed ID: 9150386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.
    Héron E; Deloukas P; van Loon AP
    Genomics; 1995 Dec; 30(3):493-505. PubMed ID: 8825636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
    Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
    Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearranged NF-kappa B2 gene in an adult T-cell leukemia cell line.
    Isogawa M; Higuchi M; Takahashi M; Oie M; Mori N; Tanaka Y; Aoyagi Y; Fujii M
    Cancer Sci; 2008 Apr; 99(4):792-8. PubMed ID: 18377428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p52 (NF-kappaB2) in LPS tolerance in a human B cell line.
    Wedel A; Frankenberger M; Sulski G; Petersmann I; Kuprash D; Nedospasov S; Ziegler-Heitbrock HW
    Biol Chem; 1999 Oct; 380(10):1193-9. PubMed ID: 10595582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of the endogenous NF-kappa B p50 subunit in the nucleus of follicular dendritic cells in germinal centers.
    Feuillard J; Körner M; Fourcade C; Costa A; Binet JL; Debré P; Raphael M
    J Immunol; 1994 Jan; 152(1):12-21. PubMed ID: 8254185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rel/NF-kappa B and I kappa B factors in oncogenesis.
    Luque I; Gélinas C
    Semin Cancer Biol; 1997 Apr; 8(2):103-11. PubMed ID: 9299588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation of nfkb2 p52: mechanism and efficiency.
    Heusch M; Lin L; Geleziunas R; Greene WC
    Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
    Watanabe M; Muramatsu M; Hirai H; Suzuki T; Fujisawa J; Yoshida M; Arai K; Arai N
    Oncogene; 1993 Nov; 8(11):2949-58. PubMed ID: 8414497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant rel/nfkb genes and activity in human cancer.
    Rayet B; Gélinas C
    Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.